This inventor holds 2 USPTO granted patents. Top assignee: Ucbbiopharma Srl. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: The Innovations of Raymond Anthony Jupp
Introduction
Raymond Anthony Jupp is a notable inventor based in Slough, GB. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 2 patents to his name, Jupp's work focuses on innovative solutions for treating diseases, including lung fibrosis.
Latest Patents
Jupp's latest patents include the development of antagonist antibodies that bind to human TGFB1, TGFB2, and TGFB3. These antibodies are designed for the treatment of lung fibrosis. The present disclosure relates to TGF-beta antibodies and binding fragments thereof, DNA encoding the same, and host cells comprising said DNA. Additionally, it outlines methods of expressing the antibody or binding fragment in a host cell. The disclosure also extends to pharmaceutical compositions comprising the antibody or a binding fragment thereof, and the use of these in the treatment of various diseases, including fibrosis.
Career Highlights
Raymond Anthony Jupp is currently associated with UCB Biopharma Srl, where he continues to advance his research and development efforts. His work has been instrumental in the field of therapeutic antibodies, contributing to innovative treatments that address critical health issues.
Collaborations
Some of Jupp's notable coworkers include Helene Bon and Joanne Elizabeth Compson. Their collaborative efforts have further enhanced the research and development initiatives within their organization.
Conclusion
Raymond Anthony Jupp's contributions to biotechnology and therapeutic antibodies highlight his role as an influential inventor. His innovative patents and ongoing work at UCB Biopharma Srl continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile